Literature DB >> 28874283

Mortality in adults with congenital heart disease.

Pavithra Naidu1, Leeanne Grigg2, Dominica Zentner2.   

Abstract

AIM: Retrospective ascertainment of the causes of mortality in the adult congenital heart disease (ACHD) cohort of the Royal Melbourne Hospital (RMH).
METHODS: Deceased patients (n=73) of the 2519 ACHD patients in the Royal Melbourne Hospital registry (commenced in 1991) were identified. Retrospective analysis was undertaken. Age, gender of deceased individuals, and frequency and cause of death in different congenital diagnosis groups was explored.
RESULTS: Between 1991 and 2015, death occurred in 3.3% of the ACHD cohort. Median age at death was 32years (IQR 26-41.5) and 51% were male. The most frequent underlying cardiac conditions were Eisenmenger's syndrome (22%), pulmonary atresia and ventricular septal defect+/-major aorto-pulmonary collateral arteries (12%), Tetralogy of Fallot (10%), transposition of great arteries (TGA) with intact ventricular septum (8%), single ventricle (8%) and congenitally corrected TGA (5%). The cause of death was available from medical records in 60 (82%) of the 73 patients. The majority of deaths were due to cardiac causes (67%) including sudden death (40%), heart failure (13%), and documented ventricular arrhythmias (8%). The most common non-cardiac cause of death was sepsis (10%).
CONCLUSION: The majority of deaths in this group were due to cardiac causes with sudden death and heart failure being the most common. Identification of risk factors for sudden death might assist identification of patients who may benefit from preventative therapies including implantable cardiac defibrillator.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adult congenital heart disease; Heart defects; Mortality

Mesh:

Year:  2017        PMID: 28874283     DOI: 10.1016/j.ijcard.2017.05.132

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease.

Authors:  Linda Wang; Neeraj Javadekar; Ananya Rajagopalan; Nichole M Rogovoy; Kazi T Haq; Craig S Broberg; Larisa G Tereshchenko
Journal:  Heart Rhythm       Date:  2020-05       Impact factor: 6.343

Review 2.  Current spectrum, challenges and new developments in the surgical care of adults with congenital heart disease.

Authors:  Jürgen Hörer
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

3.  Tetralogy of Fallot in Spain: a nationwide registry-based mortality study across 36 years.

Authors:  Laura Llamosas-Falcón; Eva Bermejo-Sánchez; Germán Sánchez-Díaz; Ana Villaverde-Hueso; Manuel Posada de la Paz; Verónica Alonso-Ferreira
Journal:  Orphanet J Rare Dis       Date:  2019-04-08       Impact factor: 4.123

4.  Prolonged Tpeak -Tend interval is a risk factor for sudden cardiac death in adults with congenital heart disease.

Authors:  Jim T Vehmeijer; Zeliha Koyak; A Suzanne Vink; Werner Budts; Louise Harris; Candice K Silversides; Erwin N Oechslin; Aeilko H Zwinderman; Barbara J M Mulder; Joris R de Groot
Journal:  Congenit Heart Dis       Date:  2019-10-01       Impact factor: 2.007

5.  Delayed diagnosis in children with congenital heart disease: a mixed-method study.

Authors:  Indah K Murni; Muhammad Taufik Wirawan; Linda Patmasari; Esta R Sativa; Nadya Arafuri; Sasmito Nugroho
Journal:  BMC Pediatr       Date:  2021-04-21       Impact factor: 2.125

6.  Factors That Influence Adherence to Medication in Adults With Congenital Heart Disease (ACHD).

Authors:  Tim Halling; Steffen Akkermann; Friederike Löffler; Adrian Groh; Ivo Heitland; Walter Emil Haefeli; Johann Bauersachs; Kai G Kahl; Mechthild Westhoff-Bleck
Journal:  Front Psychiatry       Date:  2021-11-24       Impact factor: 4.157

7.  Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease.

Authors:  Ryo Konno; Shunsuke Tatebe; Koichiro Sugimura; Kimio Satoh; Tatsuo Aoki; Masanobu Miura; Hideaki Suzuki; Saori Yamamoto; Haruka Sato; Yosuke Terui; Satoshi Miyata; Osamu Adachi; Masato Kimura; Yoshikatsu Saiki; Hiroaki Shimokawa
Journal:  PLoS One       Date:  2019-11-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.